Evidence map›Paper›PMID 30194792›Full record

ArticleCancer science2018

Girdin/GIV regulates collective cancer cell migration by controlling cell adhesion and cytoskeletal organization.

Xiaoze Wang, Atsushi Enomoto, Liang Weng, Yasuyuki Mizutani, Shaniya Abudureyimu, Nobutoshi Esaki, Yuta Tsuyuki, Chen Chen, Shinji Mii, Naoya Asai and 5 more

Open access · goldAbstract read
In one paragraph

Article in Cancer science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Iridium(III) carbene complexes as potent girdin inhibitors against metastatic cancers.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Xiaoze WangDepartment of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Atsushi EnomotoDepartment of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID http://orcid.org/0000-0002-9206-6116
Liang WengDepartment of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Yasuyuki MizutaniDepartment of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Shaniya AbudureyimuDepartment of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Nobutoshi EsakiDepartment of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Yuta TsuyukiDepartment of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Chen ChenDepartment of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Shinji MiiDepartment of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Naoya AsaiDepartment of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Hisashi HagaTransdisciplinary Life Science Course, Faculty of Advanced Life Science, Hokkaido University, Sapporo, Japan.
Sumire IshidaTransdisciplinary Life Science Course, Faculty of Advanced Life Science, Hokkaido University, Sapporo, Japan.
Kenji YokotaDepartment of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Masashi AkiyamaDepartment of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Masahide TakahashiDepartment of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID http://orcid.org/0000-0002-2803-2683
Nagoya University · JPHokkaido University · JP

Funding

Japan Agency for Medical Research and Development, Core Research for Evolutional Science and TechnologyThe Kobayashi Foundation for Cancer ResearchThe Ministry of Education, Culture, Sports, Science and Technology of Japan 15H04719The Ministry of Education, Culture, Sports, Science and Technology of Japan 26221304
6 · The paper itself

Abstract

Pathological observations show that cancer cells frequently invade the surrounding stroma in collective groups rather than through single cell migration. Here, we studied the role of the actin-binding protein Girdin, a specific regulator of collective migration of neuroblasts in the brain, in collective cancer cell migration. We found that Girdin was essential for the collective migration of the skin cancer cell line A431 on collagen gels as well as their fibroblast-led collective invasion in an organotypic culture model. We provide evidence that Girdin binds to β-catenin that plays important roles in the Wnt signaling pathway and in E-cadherin-mediated cell-cell adhesion. Girdin-depleted cells displayed scattering and impaired E-cadherin-specific cell-cell adhesion. Importantly, Girdin depletion led to impaired cytoskeletal association of the β-catenin complex, which was accompanied by changes in the supracellular actin cytoskeletal organization of cancer cell cohorts on collagen gels. Although the underlying mechanism is unclear, this observation is consistent with the established role of the actin cytoskeletal system and cell-cell adhesion in the collective behavior of cells. Finally, we showed the correlation of the expression of Girdin with that of the components of the E-cadherin complex and the differentiation of human skin cancer. Collectively, our results suggest that Girdin is an important modulator of the collective behavior of cancer cells.

Indexed as

AnimalsAntigens, CDbeta CateninBinding SitesCadherinsCell AdhesionCell Line, TumorCell MovementCytoskeletonHeLa CellsHumansMiceMicrofilament ProteinsProtein BindingSkin NeoplasmsVesicular Transport ProteinsAntigens, CDbeta CateninCadherinsCCDC88A protein, humanCDH1 protein, humanCTNNB1 protein, humanMicrofilament ProteinsVesicular Transport Proteinsactin cytoskeletoncell adhesioncollective invasioncollective migrationGirdin

Identifiers

PMID30194792
PMCPMC6215880
OpenAlexW2890649676

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.